| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |